On October 21, 2024, the Departments of Health and Human Services, Labor, and the Treasury (the Departments) issued new guidance. The guidance clarifies that with the United States Preventive Services Task Force’s (USPSTF) 2023 update to its recommendation on the prevention of acquisition of HIV, most health coverage that people receive through their employer, or purchase either through a Health Insurance Marketplace®, or directly from an insurance company are required under the ACA to cover without cost-sharing specified formulations of PrEP, including long-acting injectable PrEP and two formulations of daily oral PrEP.

Click here for more.

FAQs (PDF)